Drug: LAMIVUDINE. Injury: Neuropathy peripheral Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 105312092 | LAMIVUDINE. | Neuropathy peripheral | BRISTOL MYERS SQUIBB | 54.00 YR | M | 0 | 20160715 | MW |
| 126209111 | LAMIVUDINE. | Neuropathy peripheral | RANBAXY | 39.00 YR | M | 0 | 20160804 | HK |
| 126282691 | LAMIVUDINE. | Neuropathy peripheral | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126283371 | LAMIVUDINE. | Neuropathy peripheral | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126283511 | LAMIVUDINE. | Neuropathy peripheral | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126367621 | LAMIVUDINE. | Neuropathy peripheral | CIPLA | 0.00 | 0 | 20160809 | IT | |
| 126915911 | LAMIVUDINE. | Neuropathy peripheral | GLAXOSMITHKLINE | 47.00 YR | M | 0 | 20160826 | CN |
| 126932431 | LAMIVUDINE. | Neuropathy peripheral | VIIV | 47.00 YR | M | 0 | 20160829 | CN |
Total Records: 8 Number of Pages: 1